Basic Information
NUWIQ POWDER AND SOLVENT FOR SOLUTION FOR INJECTION 2000 IU
INJECTION, POWDER, FOR SOLUTION
Regulatory Information
SIN15923P
April 1, 2020
Prescription Only
Therapeutic
INTRAVENOUS
August 10, 2023
June 3, 2025
XB02BD02
Company Information
WELLCHEM PHARMACEUTICALS PTE LTD
WELLCHEM PHARMACEUTICALS PTE LTD
Active Ingredients
Strength: 2000 IU FVIII:C / vial
Detailed Information
Contraindications
**4.3 Contraindications** Hypersensitivity to the active substance or to any of the excipients listed in section 6.1 – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_.
Indication Information
**4.1 Therapeutic indications** Treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII deficiency). Nuwiq can be used for all age groups. Nuwiq does not contain Willebrand factor and is not indicated in von Willebrand disease.